Seaweed-Derived Bioactive Compounds Modulating MMP-2 and MMP-9 in Cancer: Redox Mechanisms and Therapeutic Limitations
Open Access
- 14 November 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1809
Abstract
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases which play essential roles in extracellular matrix (ECM) remodeling. Among them, MMP-2 and MMP-9 are mainly associated with tumor invasion, angiogenesis, metastasis, and other pathological processes such as fibrosis and inflammation, making them attractive therapeutic targets for cancer treatment. Marine natural products, particularly seaweed-derived bioactive compounds, have attracted increasing attention because of their structural diversity, broad pharmacological activities, and generally favorable biocompatibility. Seaweeds are a rich source of polysaccharides, phenolic compounds, fatty acids, pigments, vitamins, and other metabolites with anti-inflammatory, anti-oxidant, and anti-cancer properties. Growing evidence indicates that several of these compounds could suppress cancer cell proliferation, invasion, migration, and metastasis by regulating the activity and/or expression of MMP-2 and MMP-9 and their associated signaling pathways, including MAPK signaling pathways. This review comprehensively summarizes current evidence on seaweed-derived bioactive compounds as modulators of MMP 2 and MMP-9 with particular emphasis on their effects on enzymatic activity, expression, and MMP-associated signaling pathways. In addition, current limitations, translational challenges, and future perspectives for developing seaweed-derived compounds as potential MMP-targeted strategies for cancer prevention and therapy are discussed.Keywords
Funding Information
- National Research Foundation of Korea (RS-2026-25598252)
- Kongju National University
- Ministry of Education (2026-ANCHOR-12-003)
This publication has 153 references indexed in Scilit:
- Vitamins as potent cancer treatments through regulating the activity and expression of MMP ‐2 and MMP ‐9Bulletin of the Korean Chemical Society, 2026
- The Multifaceted Applications of Seaweed and Its Derived Compounds in Biomedicine and Nutraceuticals: A Promising Resource for FuturePhytochemical Analysis, 2024
- Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimatesCancer, 2024
- Potent therapeutic targets for treatment of Alzheimer's disease: Amyloid degrading enzymesBulletin of the Korean Chemical Society, 2021
- Consumer acceptability and chemical composition of whole‐wheat breads incorporated with brown seaweed (Ascophyllum nodosum) or red seaweed (Chondrus crispus)Journal of the Science of Food and Agriculture, 2020
- Flavonoids as anticancer therapies: A systematic review of clinical trialsPhytotherapy Research, 2019
- Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinaseJournal of Cellular Biochemistry, 2019
- Chemo‐preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive reviewPhytotherapy Research, 2018
- Myricetin suppresses breast cancer metastasis through down‐regulating the activity of matrix metalloproteinase (MMP)‐2/9Phytotherapy Research, 2018
- Use of inactive β‐d‐galactosidase for elimination of interference by anti‐β‐d‐galactosidase antibodies in immune complex transfer enzyme immunoassay for anti‐thyroglobulin igg in serum using β‐d‐galactosidase from escherichia coli as labelJournal of Clinical Laboratory Analysis, 1991